Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MS-SMART in secondary progressive multiple sclerosis
2012-005394-31Phase 2Completed
- Sponsor
- UCL
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amiloride, fluoxetine, riluzole in secondary-progressive multiple sclerosis (SPMS), sponsored by UCL. Started Sep 2014; status: completed.
02
Drugs
amiloridefluoxetineriluzole
03
Conditions
secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on 2012-005394-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005394-31.